Everand Logo

Welcome to Everand!

  • STAT

    Pharma tries to cash in on migraine market by making new drugs free, for now

    With intense competition in the market for new migraine headache drugs, some companies are making their medicines free to patients with private insurance.
    by Damian Garde Sep 28, 2018 2 minutes

    With approval of a new migraine therapy, Eli Lilly has become the third drug company angling for dominance in what could become a multibillion-dollar market for preventing debilitating headaches. But because none of the three medicines is clearly better than another, the contenders are taking a novel approach to competition: giving drugs away for free.

    Lilly’s treatment, called Emgality, is an

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
    More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
    Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.

    Related